Mit Blick auf den KI-Nachfrage-Ausblick lässt ein Bericht der Investmentbank TD Cowen aufhorchen: Microsoft hat demnach ...
In a report released today, Josh Jennings from TD Cowen maintained a Hold rating on Becton Dickinson (BDX – Research Report), with a price ...
TD Cowen cut shares of Akamai Technologies (NASDAQ:AKAM – Free Report) from a buy rating to a hold rating in a report issued ...
TD Cowen has upgraded CRISPR Therapeutics (CRSP) to hold from sell, stating it now sees less downside to the stock. Read more ...
TD Cowen analyst Stacy Ku maintained a Buy rating on VYNE Therapeutics (VYNE – Research Report) today and set a price target of $5.00. The company’s shares closed yesterday at $2.52.
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced that members of its management team will participate in the TD Cowen 2nd ...
Cowen notes that Microsoft is citing construction delays and lack of access to power as excuses for trying to get out of its ...
TD Cowen raised the firm’s price target on DraftKings (DKNG) to $60 from $51 and keeps a Buy rating on the shares. The firm raised its ...